Twinstrand Therapeutics (Burnaby, BC)

CMDF Investment: $4,084,000.00
Focus: Aids   Cancer   Infectious Dieases  
www.twinstrand.com

Twinstrand Therapeutics Inc. is a privately owned biopharmaceutical company (incorporated in 1995) with modern laboratories and offices in the Vancouver suburb of Burnaby; British Columbia. Twinstrand specializes in the development of recombinant therapeutics for the treatment of human diseases. Using molecular genetic and combinatorial methods; the company is advancing a family of prodrugs that are activated by disease-associated proteases. Twinstrand's molecules have a wide range of potential applications in the treatment of diseases such as cancer; HIV/AIDS; hepatitis A and C; cytomegalovirus and herpes. Cancer is the leading application of the company's technology.